Skip to main content
. 2018 Aug 12;2018:1597964. doi: 10.1155/2018/1597964

Table 3.

Log rank test estimation of discontinuation of breast cancer patients by clinical features, at UCH, Ibadan, 2001-2010.

Variable MDT Log rank SE[s(t)] 95%CI P value
(months) Chi-square
Age
 Younger patients 44.0 3.498 2.965 38.18-49.81 0.061
 Older patients 44.0 2.325 39.44-48.56

Educational level
 Primary school and below 41.0 1.053 2.195 36.70-45.30 0.305
 Secondary school and above 47.0 2.265 42.60-51.40

Marital status
 Not married 39.0 8.289 2.315 34.50-43.50 0.004
 Married 45.0 1.954 41.20-48.80

Menopausal status
 Premenopausal 44.0 2.965 3.356 39.40-52.60 0.085
 Postmenopausal 45.0 1.876 41.30-48.70

Duration of symptoms before diagnosis
 Up to 12 months 47.0 4.868 2.233 42.60-51.40 0.027
 Above 12 months 37.0 1.914 33.20-40.8

Distance of home town to UCH to Ibadan
 >250KM 46.0 0.282 2.252 41.60-50.40 0.596
 ≤ 250KM 41.0 2.772 35.60-46.40

Stage of disease
 Early stage (I&II) 51.0 19.500 2.416 46.30-55.70 <0.001
 Late stage (III&IV) 37.0 1.542 34.00-40.00

Axillary node status
 No axillary nodes 51.0 1.600 6.717 38.00-64.00 0.198
 Presence of axillary nodes 44.0 2.023 40.00-48.00

Grade of differentiation
 Well differentiated 41.0 1.360 2.729 35.70-46-30 0.244
 Moderate/poorly differentiated 45.0 2.334 40.40-49.60

Metastasis
 Presence of metastasis 31.0 49.761 2.233 26.60-35.40 <0.001
 No metastasis 51.0 2.213 46.70-55.30

Baseline packed cell volume
 Low PCV 38.0 18.775 2.147 33.80-42.20 <0.001
 Normal PCV 47.0 2.183 42.70-51.30

MDT= median discontinuation time; CI= confidence interval; SE= standard error.